Home LiteratureArticle Details
PMID: 9334801 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Effect of parity and age at delivery on breast cancer risk in Slovenian women aged 25-54 years.

International journal of cancer ·Vol. 73 ·No. 1 ·1997-09-26 ·Pages 1-9

Robertson C, Primic-Zakelj M, Boyle P, Hsieh CC

Abstract

In 1988, a case-control study on breast cancer and oral contraceptives with 624 cases and 624 matched controls in the age range 25-54 years was undertaken in Slovenia. This analysis assesses the relationship between parity and breast cancer risk: the relative importance of age at first birth, age at subsequent births and total parity. We also evaluate whether a dual effect of an increased risk immediately after childbirth followed by a long-term benefit exists. Three logistic regression models were used. Age at first delivery is an important breast cancer risk factor: among parous women it was associated with a 5.3% increase/year in the odds of breast cancer. Multiparity was not shown to be an independent risk factor. Age at subsequent deliveries was associated with a 1% increase in risk for every 1 year increase of age at any birth, but this contribution to the risk was not significant. In the analysis stratified by parity the most important influence is with the age at first birth. We find no evidence of an effect on the odds of breast cancer associated with the age at the second, or later, births. We do find that there is an increased risk associated with the birth of the first child followed by a longer term protective effect. A post-menopausal woman has a reduced breast cancer risk compared with a pre-menopausal woman of the same age, adjusting for the same number of deliveries and ages at these deliveries.

MeSH Terms
Adult Breast Neoplasms/etiology Case-Control Studies Female Humans Maternal Age Middle Aged Parity Risk Factors
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Robertson C
Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy. crobert@ieo.it
Primic-Zakelj M
Boyle P
Hsieh C C
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
1997-09-26
Pages
1-9
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com